Exicure is a Chicago, Illinois-based biotechnology company that was founded in 2011.
ExicureExicure is a biotech company that develops nucleic acid-based therapeutics to treat rare and severe genetic diseases and cancer. The company has an SNA technology that enables the delivery of genetically-targeted therapies to a broad range of tissues and cells.